These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9205086)

  • 21. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
    Chen GG; Lai PB; Ho RL; Chan PK; Xu H; Wong J; Lau WY
    J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutathione S-transferase enzyme expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes in erythroid and for M1 in lymphoid lineages.
    Wang L; Groves MJ; Hepburn MD; Bowen DT
    Haematologica; 2000 Jun; 85(6):573-9. PubMed ID: 10870112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma.
    Yang EB; Qin LL; Zhao YN; Zhang K; Chow P
    Int J Mol Med; 2003 Jun; 11(6):773-8. PubMed ID: 12736721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of glutathione S-transferase and its Pi isoenzyme in tumor tissues and sera of patients with ovarian cancer.
    Ghalia AA; Rabboh NA; el Shalakani A; Seada L; Khalifa A
    Anticancer Res; 2000; 20(2B):1229-35. PubMed ID: 10810426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aflatoxin, liver enzymes, and hepatitis B virus infection in Gambian children.
    Wild CP; Fortuin M; Donato F; Whittle HC; Hall AJ; Wolf CR; Montesano R
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):555-61. PubMed ID: 8268773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
    Wang XH; Wang PL
    Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
    Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
    Chen Ban K; Singh H; Krishnan R; Fong Seow H
    J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of cytochrome P-450 and glutathione S-transferase activity in normal and malignant human stomach.
    Kim HS; Kwack SJ; Lee BM
    J Toxicol Environ Health A; 2005 Oct; 68(19):1611-20. PubMed ID: 16195217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
    Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.
    Evans AA; O'Connell AP; Pugh JC; Mason WS; Shen FM; Chen GC; Lin WY; Dia A; M'Boup S; Dramé B; London WT
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):559-65. PubMed ID: 9681522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma.
    Wong DK; Yuen MF; Poon RT; Yuen JC; Fung J; Lai CL
    J Hepatol; 2006 Oct; 45(4):553-9. PubMed ID: 16904225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients.
    Wang J; Qin Y; Li B; Sun Z; Yang B
    Clin Biochem; 2006 Apr; 39(4):344-8. PubMed ID: 16527261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
    Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
    J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.